Literature DB >> 6700042

Oral contraceptives, pregnancy, and focal nodular hyperplasia of the liver.

L D Scott, A R Katz, J H Duke, D F Cowan, N F Maklad.   

Abstract

There is uncertainty regarding the role, if any, of oral contraceptive steroids in the development of focal nodular hyperplasia of the liver. In a 36-year-old woman, a large left hepatic lobe tumor developed that was detected after 11 years of using these drugs. The tumor regressed when administration of the drug was stopped but began to increase in size during a subsequent pregnancy. A left hepatic lobectomy during the second trimester disclosed focal nodular hyperplasia. Both contraceptive steroids and pregnancy, with high levels of endogenous sex steroids, favored tumor growth in this patient, suggesting that focal nodular hyperplasia can be steroid related.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6700042

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  15 in total

1.  Focal nodular hyperplasia of the liver: results of treatment and options in management.

Authors:  J A Pain; A E Gimson; R Williams; E R Howard
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

2.  Failure of hepatic adenomas (HCA) to regress after discontinuance of oral contraceptives. An association with focal nodular hyperplasia (FNH) and uterine leiomyoma.

Authors:  W H Marks; N Thompson; H Appleman
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

Review 3.  A case of hepatocellular carcinoma arising within large focal nodular hyperplasia with review of the literature.

Authors:  Theodoros Petsas; Athanassios Tsamandas; Irene Tsota; Dionisios Karavias; Chrysoula Karatza; Vassilios Vassiliou; Dimitrios Kardamakis
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

Review 4.  Hepatobiliary complications of oral contraceptives.

Authors:  M C Lindberg
Journal:  J Gen Intern Med       Date:  1992 Mar-Apr       Impact factor: 5.128

5.  Oral contraceptives and primary liver cancer among young women.

Authors:  A W Hsing; R N Hoover; J K McLaughlin; H T Co-Chien; S Wacholder; W J Blot; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

6.  Fibrolamellar hepatocellular carcinoma in pregnancy.

Authors:  M W Louie-Johnsun; P M Hewitt; D S Perera; D L Morris
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

7.  Hepatocellular carcinoma in a patient with focal nodular hyperplasia.

Authors:  Craig M Coopersmith; Jeffrey A Lowell; Anjum Hassan; Todd K Howard
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

8.  Diagnosis and management of hepatic focal nodular hyperplasia.

Authors:  A Venturi; F Piscaglia; G Vidili; S Flori; R Righini; R Golfieri; L Bolondi
Journal:  J Ultrasound       Date:  2007-08-01

9.  Oral contraceptives and focal nodular hyperplasia of the liver.

Authors:  Z J Hagay; R J Leiberman; M Katz; A Witznitzer
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

Review 10.  Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma.

Authors:  D M Nagorney
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.